Cerebral Blood Flow Measurement of MRI using PSO17 in Normal Subjects
Phase 1
- Conditions
- brain infarction, brain tumor, epilepsy
- Registration Number
- JPRN-UMIN000029935
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
(1)metallic implant or claustrophobia (2)blood flow abnormality by Allen test (3)chronic disorders (4)CNS, liver, kidney or heart disease (5)acute infection before 30 days (6)drug allergy (7)chronic intake of drugs (> 30 days) (8)other clinical trial within 90 days (9)willing to have babies or during breast feeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method